Last month, Content
Checked Holdings, Inc. (OTCQB: CNCK) announced the addition of Dr. Göran Rune
Skog to its board of directors. For more than 35 years, Dr. Skog has worked in
the medical field, specializing in orthopedic medicine, physical medicine,
research and surgery, invasive pain management and rehabilitation. Currently,
he serves as the head of the Spine Treatment Unit at the NIMI Hospital in Oslo,
Norway; maintains a private practice in Stockholm, Sweden; and serves as the
associate professor at Cedarcrest Hospitals in Abuja, Nigeria.
“Göran understands
the critical role that nutrition plays in everyday life and knows nutrition
strategies that really make sense,” Kris Finstad, President and CEO of CNCK,
stated in a news release. “We were determined to find a board member with all
of the attributes that Göran embodies and we are proud to welcome such an
outstanding individual and leading medical authority to our board. I am
confident that Göran is going to make a significant and positive impact on our
Company.”
In addition to his
extensive medical experience, Dr. Skog is also a man of considerable business
acumen. He previously served as the CEO and Director of the Swedish Orthopedic
Medicine Society, and he’s currently a member of the board of directors of
Active Life Foundation, SEB (Skandinaviska Enskilda Banken).
“I have a long-term
interest in nutritional, dietary, medical technology and the process of guiding
innovative companies to make a positive impact in people’s lives, hit business
milestones and expand into new markets,” Dr. Göran Skog stated in a news
release. “I am excited by what Content Checked has accomplished and I am
honored to be joining their board.”
For CNCK, the
election of Dr. Skog to its board of directors continues to set the stage for
its planned uplisting to the NASDAQ exchange. Last month, the company announced
the engagement of Bonwick Capital Partners LLC as its financial and corporate
advisor. Among other advisory services, Bonwick is expected to assist CNCK with
its planned application submission for uplisting later this fiscal year. Before
the company can qualify for uplisting, however, it will be required to adhere
to the corporate governance standards set forth by NASDAQ, including the
election of independent directors to its board.
Through the addition
of Dr. Göran Skog to its board of directors last month, CNCK made noteworthy
progress toward the accomplishment of two goals. First, the company is now
positioned to benefit from the extensive medical and nutritional experience of
its newest board member, as well as his knowledge and medical community
network. Second, CNCK moves one step closer to qualifying for the NASDAQ exchange
by electing a highly-qualified, independent director.
To view the
Company’s full financials, visit the following link: http://dtn.fm/sIJ7M
For more
information, visit www.contentchecked.com
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
